Cipla Limited share price

Key numbers

Market cap

₹ 1,13,078 Cr

Current price

₹ 1,399.70

52-week high / low

₹ 1,673 / 1,166

Stock P/E

33.6

Book value

₹ 426.3

Dividend yield

0.93%

ROCE

15.8%

ROE

11.8%

Debt to equity

0.02

Sales growth (3 yrs)

7.2%

Profit growth (3 yrs)

11.5%

1-year return

-9.0%

About Cipla Limited

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney disorders, alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Quarterly results

Consolidated figures in ₹ crores

Peers in Drug Manufacturers - Specialty & Generic

• Sun Pharmaceutical Industries Limited
• Divi's Laboratories Limited
• Torrent Pharmaceuticals Limited
• Zydus Lifesciences Limited
• Laurus Labs Limited
• Mankind Pharma Limited
• Dr. Reddy's Laboratories Limited
• Aurobindo Pharma Limited
• Lupin Limited
• Glenmark Pharmaceuticals Limited